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Septic arthritis, also known as infectious arthritis 
represents a direct invasion of joint space by 
various pathogens most commonly caused by a  
 
variety of bacteria. However, viruses, mycobacteria, 
and fungi have been implicated.[1] Septic arthritis is 
due to inflammation in the joint that is of an 
infectious etiology.[2] With regards to the outcome of 
septic arthritis, early diagnosis and prompt 
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Background: Septic arthritis is an inflammatory process in the joints associated with isolation of 
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present our findings with the view towards improving treatment outcomes in similar clinical 
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recurrent bouts of fever, joint tenderness reduced mobility and swelling. The predisposing factor 
in the index patient, a seven year old male was sickle cell disease. Multiple antimicrobial 
regimens were instituted in the patient with unsatisfactory results. Initial treatment regimens did 
not appear to be based on bacteriological statistics which resulted in prolonged hospital stay. 
Culture of the synovial fluid was initially onto brain heart infusion both and subsequently sub-
cultured onto chocolate and MacConkey agar. The isolate recovered was Serratia rubideae 
which was identified using the Microbact 12A kit. Susceptibility studies showed the isolate to be 
susceptible to only meropenem. The patient was subsequently placed on meropenem for forty 
two days and recovered with radiologic and clinical evidence of improvement and thereafter 
discharged home. Conclusion: Close collaboration between the orthopedic surgeon and 
microbiologist will help to improve treatment outcomes. The Microbact12A kit is recommended 
in the routine identification of gram negative pathogens. 
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treatment are both essential in order to achieve 
good clinical results. 
 
The most common bacterial isolates globally in 
native joints include gram-positive cocci, with 
Staphylococcus aureus found in 40% to 50% of 
reported cases.[3] Salmonella typhi and Klebsiella 
spp are also implicated especially in sickle cell 
disease.[3,4] Anaerobes such as Bacteroides fragilis 
have also been found in septic arthritis especially 
following bacteremia.[3] Other pathogens include 
Neisseria gonorrhoeae, Streptococci, and Gram-
negative cocci, each in about 10% to 20% of 
cases.[4] Organisms less commonly isolated are 
mycobacteria and fungi. Gram-negative bacilli such 
as Klebsiella spp and Enterobacter sppare often 
present in neonates, the elderly, and patients with 
immune deficiency disorders.[5] Neisseria 
gonorrhoeae is seen in sexually active young 
adults, usually with associated dermatitis and 
tenosynovitis.[3,4,5] Mycobacterial infections should 
be suspected in patients from endemic areas, and 
fungal arthritis is seen in immunocompromised 
patients.[3,4,5] 
 
Haemophilus influenzae was a common cause of 
bacterial arthritis in young children, but the 
incidence has decreased almost 70% to 80% since 
the widespread use of H. influenza type b conjugate 
vaccine.[6] Organisms such as coagulase negative 
Staphylococci and Propionibacterium spp tend to 
contaminate surgical sites following repair of 
anterior cruciate ligaments.[6,7] 
 
The signs and symptoms of septic arthritis include 
joint pain, swelling and soreness with joint 
immobility; fever may also be present. Additional 
clinical features that are associated with arthritis are 
nausea, vomiting and diarrhea which represent a 
systemic upset.[8] 
 
Identified risk factors for septic arthritis are sickle 
cell disease, joint surgery, bacteremia, diabetes 
mellitus, malignancy, and rheumatoid arthritis. 
Others include sexually transmitted diseases such 
as gonorrhea, systemic lupus erythematosis, 
intravenous drug use, anemia, hemodialysis and 
the extremes of life.[9] 
 
Laboratory features that point towards joint infection 
include an elevated white cell count obtained from 
the synovial fluid with differentials for polymorphs, 
and crystal examination under a polarized 
microscope.[10] A synovial fluid leukocyte count of 
greater than 50,000 with polymorphonuclear 
leukocyte predominance is usually seen in septic 
arthritis.[10] The gram stain is positive in about 11 to 
80% of cases and as such can be a valuable tool in 
diagnosis. Synovial fluid culture is also positive in 
up to 90% of non-gonococcal septic arthritis.[10] 
 
As a result of the absence of a limiting membrane 
plate in synovial tissue, pathogens gain access via 
the haematogenous route into joint spaces in 
predisposed individuals. This also tends to follow 
bacteremia. Other routes include direct access 
following trauma or surgery particularly after 
prostheses have been implanted.  
 
The optimal management of arthritis involves the 
use of agents that can penetrate sufficiently into 
bone tissue and these include antimicrobials such 
as third generation cephalosporins, vancomycin, 




We present a seven-year old male patient who is a 
known sickle cell disease patient diagnosed since 
the age of one. The index patient presented with a 
month history of bilateral knee joint pain which were 
swollen and warm. There was no antecedent 
history of falls or trauma to the knees. In addition 
there were no known relieving factors for the pain, 
but it was aggravated by movement. There was 
also no prior history of surgery. Patient had been to 
a private health care facility and was on admission 
for twenty six days from where he was referred to 
LUTH on account of non-response to treatment. 
 
While on admission, pain in the left leg resolved 
after ten days. There was also a history of fever 
which was low grade, persistent, and relieved by 
paracetamol though transiently. The paracetamol 
(450 mg) was administered as a slow infusion via a 
normal saline bag over six hours. While on 
admission, the patient was said to have had 
bronchopneumonia and congestive cardiac failure 
and was transfused with packed cells on four 
different occasions due to a concomitant low 
packed cell volume.  
 
At the referral hospital he was placed on the 
following antibiotics in sequential order: Intravenous 
crystalline penicillin 1mU 12 hourly for 4 days, 
intravenous ciprofloxacin 200mg 12 hourly for two 
days, ampicillin-sulbactam and ceftazidime for 3 
days intravenously. intravenous levofloxacin for 
three days , intravenous vancomycin for 8 days with 
anti-Koch’s medication all with minimal 
improvement. The administration of anti-Koch’s was 
a last gasp measure by the managing team due to 
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No malaria parasite was seen on thick and thin 
films. Widal test for Salmonella typhi IgM was 
negative, while the PCV was 25% at admission. 
 
Ultrasound scan of the right knee was indicative of 
soft tissue abscess collection in the right popliteal 
area indicative of osteomyelitis. X-ray of the right 
thigh showed a bone in bone appearance in the 
distal 3rd of the femur (osteomyelitis of distal 3rd of 
right femur). X-ray of the right leg area showed a 
collection in the proximal tibial metaphysis with an 
area of cortical discontinuity with slight angulations 
in the medial aspect of the proximal tibial 
metaphysis- green stick fracture of proximal 3rd of 
right tibia. The X-ray on the left knee joint revealed 
an area of translucency though of a much smaller 
size compared tothe right knee Joint which was 
much larger. Periarticular soft-tissue swelling of 
both right and left knee joints were seen on the X-
rays. 
 
A needle aspirate with repeating joint taps was 
frequently done to prevent significant re-
accumulation of fluid. Aspirating the joint 2-3 times 
a day was performed. As a result of this open 
surgical drainage and large volume irrigation with 
normal saline, and immobilization was conducted. 
 
Right hip joint aspirate was sent for microscopy 
culture and susceptibility, and a coliform was 
isolated and subsequently identified with 
Microbact12A kit as Serratia rubideae and was also 
sensitive to meropenem. 
 
Medications on admission in LUTH sequentially 
were IV ceftriaxone 1g daily 12 hourly, meropenem 
330mg 12hourly, IV amikacin 125mg 8 hourly, IV 
pentazocine 15mg for pain , oral ibuprofen 160mg 6 
hourly (with foods alternating  with paracetamol 
160mg). 
 
All intravenous antibiotics were discontinued when 
there was no symptom resolution and he was 
placed on intravenous vancomycin 10 mg/kg 12 
hourly which was again discontinued based on the 
susceptibility results and accurate identification of 
the offending pathogen and re-introduction of 
meropenem which was administered for 42 days. 
There was steady improvement with consistent 
administration of meropenem and joint function was 
restored with resolution of tenderness and swelling. 
He was discharged home on cefepime and came 
back to the clinic for follow up appointments 




This study documents the case of a seven-year old 
sickle cell disease patient who developed bone and 
joint pains (knee) of four weeks duration. The child 
at that point in time had a vaso-occlusive crisis 
necessitating blood transfusion at the referral 
hospital where he spent twenty six days. Due to 
non-improvement in the patient’s condition he was 
referred to LUTH. Upon admission he was placed 
on the following drugs sequentially: IV ceftriaxone 
1g 12hourly for 1 day, IV meropenem 330 mg 12 
hourly and amikacin for 5 days, IV vancomycin 10 
mg/kg 12 hourly for 8 days and finally IV 
meropenem 330 mg 12 hourly for 13 days (after 
Serratia rubideae was isolated and showed 
sensitivity to meropenem, bone pains subsided, 
minimal reduction in joint swelling). 
 
Despite arthrocentesis, the clinical signs did not 
abate and this warranted prolonged therapy with 
meropenem for forty two days. The definitive 
diagnosis of joint fluid aspiration aided in isolating 
the offending pathogen, Serratia marcescens, via 
the use of the Microbact 12A kit. Treatment, 
irrigation and debridement of the joint still did not 
resolve the patient’s clinical condition as the initial 
antimicrobial regimen was sub optimal; however 
this should be done till wound granulation is seen 
alongside appropriate antibiotics in order to achieve 
optimal results. 
 
Septic arthritis still remains an important and 
serious disease of the young because of its high 
potential to cause permanent sequelae, therefore 
aggressive therapy with the appropriate 
antimicrobial is essential.[12,13] It is a challenging 
clinical problem because signs and symptoms may 
be subtle and overlap with those found in other 
conditions, screening laboratory studies and 
synovial fluid cultures are relatively insensitive and 
optimal management, including duration of 
antibiotics and surgical approach is not always 
evidence based.[14] 
 
The treatment of septic arthritis involves urgent 
surgical drainage and lavage of the joint. This can 
be performed arthroscopically or via an open 
arthrotomy.[1] In the paediatric setting, the knee and 
shoulder joints are often approached 
arthroscopically, whereas the hip and ankle joints 
are generally approached via an arthrotomy.[1] In 
very young children, standard arthroscopic 
Shobowale and Akinmokun. Bilateral septic arthritis and sickle cell disease 




instruments are too large and, therefore, arthrotomy 
is generally performed.[1] 
 
Acute septic arthritis may develop as a result of 
hematogenous seeding, direct introduction, or 
extension from a contiguous focus of infection. The 
pathogenesis of acute septic arthritis is 
multifactorial and depends on the interaction of the 
host immune response and the adherence factors 
of different pathogens, the toxins they elaborate 
and immunoavoidance strategies of the invading 
pathogen.[15] 
 
While diagnosis rests on isolation of the bacterial 
species from synovial fluid samples, patient history, 
clinical presentation, laboratory findings, and 
imaging studies are also important. Acute septic 
arthritis is a medical emergency that can lead to 
significant morbidity and mortality. Therefore, 
prompt recognition, rapid and aggressive 
antimicrobial therapy, and surgical treatment are 
critical to ensuring a good prognosis. Even with 
prompt diagnosis and treatment, high mortality and 
morbidity rates still occur.[15] 
 
 
Table 1: Susceptibility results performed with oxoid discs  
 
 
CAZ TZP CRO CEF AMX CIP AMC CN MEM CFX 
R R R R R R R R S S 
 
Key: CAZ – Ceftazidime, TZP – Piperacillin Tazobactam, CEF – Cefuroxime, AMX – Amoxicillin, CIP – 
Ciprofloxacin, CN – Gentamicin, MEM – Meropenem, CFX–Cefixime 










In the index case, sickle cell disease was the risk 
factor for septic arthritis. Concerted efforts must be 
made to rapidly identify septic arthritis in this at risk 
group. In septic arthritis, early diagnosis and 
treatment is quite important. In this study, we 
presented a case with both knee joints involved in 
septic arthritis. The patient, a-seven year old male 
with underlying sickle cell disease had a protracted 
course with several antimicrobial regimens. Close 
collaboration between the orthopedic surgeon and 
microbiologist ultimately helped to improve the 
outcome. The Microbact12A kit is recommended as 
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